QNRX QUOIN PHARMACEUTICALS LTD Capital Structure Changes 8-K Filing 2023 - Ratio Change for ADSs Quoin Pharmaceuticals approved a change in the ratio of its American Depositary Shares (ADSs) from 1 ADS representing 5,000 Ordinary Shares to 1 ADS representing 60,000 Ordinary Shares, resulting in a one for twelve split of issued and outstanding ADSs.Get access to all SEC 8-K filings of the QUOIN PHARMACEUTICALS LTD